Manufacturer: Pfizer Animal Health Registered Name Fevac F4 Vaccine Composition Inactivated vaccine containing feline rhinotracheitis virus (FVR 605), calicivirus (FCV 255), panleucopenia virus (FPV CU-4), and Chlamydia psittaci (CELLO), R.P. greater than or equal to 1.0. Indications Active immunisation of healthy cats 8 weeks of age or older to aid in the reduction of clinical symptoms caused by infection with feline rhinotracheitis virus, panleucopenia virus, feline calicivirus and Chlamydophila (Chlamydia) psittaci. This vaccine does not prevent infection or shedding. Based on overseas challenge data, it has been demonstrated that clinical signs of feline calicivirus infection (pyrexia, ulcers) are likely to occur in vaccinated animals following exposure to this virus. However the severity of the fever and ulcers is likely to be reduced compared to unvaccinated animals. Precautions Vaccinate only healthy cats or kittens with normal temperatures. Animals under treatment with immunosuppressive drugs should be vaccinated with caution. Studies to support the use of the product in pregnant queens have not been conducted. First aid. Accidental self-injection may lead to an inflammatory response and medical advice should be sought on the management of deep injections, particularly those near a joint or associated with bruising. If possible the application of gentle squeezing pressure with absorbent material (e.g. facial tissues) at the injection site will swab up unabsorbed vaccine. Strong squeezing of the site should be avoided. The damaged area should be thoroughly cleansed and a topical antiseptic applied. Disposal. Dispose of empty vial by wrapping with paper and putting in garbage. Discarded syringes and needles should immediately be placed in a designated and appropriately labelled sharps container. Adverse Reactions Some animals may show transient postvaccination pain, malaise and depression. Allergic reactions such as anaphylaxis occur rarely and may require parenteral treatment with an antihistamine, a corticosteroid or adrenaline as appropriate. Local site reactions after vaccination are rare but transient swelling, pain and subcutaneous thickening may occur. Dosage and Administration Shake the vial well to obtain a uniform suspension of vaccine before administration. The entire contents of the vial should be used immediately after opening. The vaccine may be administered either intramuscularly (in the thigh) or subcutaneously. Each vial contains a single dose (1 mL) of vaccine. Recommended vaccination program. Fevac F4 Vaccine can be used on its own or as part of a standard vaccination program. Primary immunisation for cats aged 8 weeks and older consists of two 1 mL doses of the vaccine given at an interval of three to four weeks. It is also recommended that an annual booster with a single dose of vaccine be administered.
